AACR Virtual Meeting I & II: Platforms for COVID-19 and Cancer Discussions
The COVID-19 pandemic remains at the center of health and science news as cases of the disease continue to rise...
The COVID-19 pandemic remains at the center of health and science news as cases of the disease continue to rise...
As a scientific organization focused on preventing and curing all cancers, the American Association for Cancer Research (AACR) embraces...
This month, the editors of the AACR’s journals have chosen to highlight an analysis of birth characteristics and risk...
Following the resounding success of the First Virtual Annual Meeting with more than 61,000 attendees in April, the AACR...
Epithelial ovarian cancer is by far the most common ovarian cancer subtype, accounting for 90 percent of ovarian cancers. The...
“The field of cell therapy is one of the most exciting fields in translational medicine,” began Katayoun Rezvani, MD, PhD,...
Over the course of the two-day AACR Virtual Annual Meeting I, more than 61,000 people from 140 countries around the...
At the time of this writing, more than 3.3 million individuals have been diagnosed with COVID-19, and more than 222,000 have died from the...
A short time after Mallika Lala, PhD, finished her presentation titled “Pembrolizumab 400 mg Q6W dosing: First clinical outcomes...
Early detection of most cancers is an elusive and daunting task; nevertheless, it has remained a top priority for...